Walgreens Boots Alliance Bolsa (NASDAQ: WBA)

Últimas noticias sobre Walgreens Boots Alliance (NASDAQ:WBA) Bolsa

WALGREENS BOOTS ALLIANCE INC

Walgreens Boots Alliance

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Microstrategy, Qualcomm, Arm Holdings, Ford, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Equities

News

Markets

AVGO

COST

LUNR

TSLA

El mercado de valores cayó con fuerza ayer. Descubre qué acciones fueron las más negociadas y cómo impactó la jornada en los traders.

Broadcom, Costco, Intuitive Machines, Walgreens y Tesla: 5 acciones que están en el radar de los inversores

AAPL

INTC

El mercado de valores de EE.UU. cerró en positivo pese al débil crecimiento del PIB. Descubre qué acciones sorprendieron a los inversores.

Apple, Intel, Walgreens, UPS y Tesla: 5 acciones que están en el radar de los inversores

Short Ideas

Pre-Market Outlook

Trading Ideas

CHEF

Chefs&#39; Warehouse y Walgreens Boots Alliance destacan en el sector de bienes de consumo básico con altos valores de RSI.

Acciones en sobrecompra: Chefs&#39; Warehouse y Walgreens Boots Alliance en el radar

Walgreens Boots Alliance, Inc. - Common Stock

Walgreens Boots Alliance Inc

WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 6.94%</li>
<li>B of A Securities analyst Lisa Lewandowski upgraded the stock from Neutral to Buy and increased the price target from $55 to $65 on Dec. 6, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and raised the price target from $45 to $46 on Nov. 6, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On Jan. 30, the company posted upbeat quarterly sales.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">latest MO news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="858" height="755" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21.png" alt="" class="wp-image-852766" style="width:527px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21.png 858w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21-300x264.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042845/image-21-768x676.png 768w" sizes="(max-width: 858px) 100vw, 858px" /></a></figure>
<h3 class="wp-block-heading">Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)</h3>
<ul>
<li>Dividend Yield: 8.96%</li>
<li>Deutsche Bank analyst George Hill downgraded the stock from Hold to Sell and cut the price target from $11 to $9 on Feb. 28, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Truist Securities analyst David Macdonald maintained a Hold rating and cut the price target from $13 to $12 on Jan. 31, 2025. This analyst has an accuracy rate of 68%</li>
<li>Recent News: On March 6, Walgreens announced it entered into a definitive agreement to be taken private by an entity affiliated with Sycamore Partners for $10 billion.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">latest WBA news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="922" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22.png" alt="" class="wp-image-852768" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22.png 922w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042917/image-22-768x696.png 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h3 class="wp-block-heading">B&amp;G Foods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGS#NYSE">BGS</a>)</h3>
<ul>
<li>Dividend Yield: 10.92%</li>
<li>Piper Sandler analyst Michael Lavery maintained a Neutral rating and lowered the price target from $8 to $7 on Feb. 26, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Barclays analyst Brandt Montour maintained an Equal-Weight rating and cut the price target from $8 to $7 on Nov. 7, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Feb. 25, B&amp;G Foods posted better-than-expected quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest BGS <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0402"><img loading="lazy" decoding="async" width="920" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4.png" alt="" class="wp-image-852769" style="width:565px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/02042949/image-1-4-768x698.png 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44600914/unifirst-blackberry-and-3-stocks-to-watch-heading-into-wednesday">UniFirst, BlackBerry And 3 Stocks To Watch Heading Into Wednesday</a> </li>
</ul>
Photo via Shutterstock

Dividends

Price Target

Analyst Ratings

Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields

Walgreens Boots Alliance's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NYSE">WBA</a>) short percent of float has fallen 6.14% since its last report. The company recently reported that it has 62.97 million shares sold short, which is 8.72% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Walgreens Boots Alliance Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742414449_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Walgreens Boots Alliance has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Walgreens Boots Alliance's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Walgreens Boots Alliance's peer group average for short interest as a percentage of float is 1.24%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

How Is The Market Feeling About Walgreens Boots Alliance?

Earlier this month, Sycamore Partners agreed to acquire Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) for $11.45 per share <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">in cash at closing</a>. Shareholders are also eligible to receive up to $3 in cash per share from the future monetization of Walgreens&#8217; debt and equity interests in VillageMD, which includes the Village Medical, <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44182479/walgreens-stock-rises-as-company-inks-10b-deal-to-go-private" target="_blank" rel="noreferrer noopener">Summit Health and CityMD businesses</a>.
Soon after, Gary Black, managing partner at The Future Fund LLC, said, &#8220;I&#8217;ve talked before about how this company shouldn&#8217;t be public,&#8221; adding that the move is driven by its largest shareholder, executive chairman Stefano Pessina, who <a href="https://www.benzinga.com/markets/equities/25/03/44185847/gary-black-says-walgreens-is-a-company-that-shouldnt-be-public-cites-largest-shareholders-role-in-10-billion-sycamore-deal" target="_blank" rel="noreferrer noopener">holds a 16.9% stake</a>.
The Financial Times, citing sources, writes that Stefano Pessina plans to nearly double his stake in the company to about 30% as part of its acquisition.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43104245/justice-department-accuses-walgreens-of-violating-drug-laws-in-opioid-epidemic-ignored-red-flags-in-opioid-crisis" rel="noreferrer noopener">Justice Department Accuses Walgreens Of Violating Drug Laws In Opioid Epidemic, Ignored Red Flags In Opioid Crisis</a>
The move signals Pessina&#8217;s deepening involvement in the company&#8217;s future, potentially ahead of a breakup of its various business units.
The FT report <a href="https://www.ft.com/content/ef898a28-ed96-45b5-baae-7569b8b778a3" target="_blank" rel="noreferrer noopener">added</a> that the transaction will allow Walgreens to restructure the struggling pharmacy giant. Walgreens is currently in a 35-day window to evaluate competing offers.
Pessina&#8217;s existing stake is worth approximately $2.1 billion. The deal&#8217;s complex financing structure is expected to allow Sycamore to potentially separate Walgreens&#8217; various business units into independent entities, reviving the possibility of selling Boots after <a target="_blank" href="https://www.benzinga.com/m-a/22/01/24860084/bain-capital-reportedly-eyeing-boots-uk-takeover-from-walgreens-report" rel="noreferrer noopener">previous failed attempts</a>.
Walgreens&#8217; market value once exceeded $100 billion following the 2014 merger of Walgreens and Alliance Boots, a deal orchestrated by Pessina. However, the company&#8217;s value has since fallen below $10 billion, facing mounting challenges from online competitors and shifting consumer habits.
Sources indicate that Pessina played a key role in securing the Sycamore deal as he sought a solution to Walgreens&#8217; declining stock price.
In January,&nbsp;Walgreens reported first-quarter sales of $39.46 billion, up 7.5% year over year (+6.9% on constant currency), beating the&nbsp;consensus of $37.28 billion, reflecting sales growth <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/42912519/walgreens-boots-alliance-stock-jumps-on-better-than-expected-q1-earnings-sticks-to-annual-profit-forecast" rel="noreferrer noopener">across all segments</a>.
Analysts estimate Walgreens&#8217; second quarter 2025 adjusted EPS of 53 cents, with sales of $37.9 billion. Wall Street forecasts 2025 adjusted EPS of $1.61 and <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">sales of $151.6 billion</a>.
Price Action: WBA stock is down 0.04% at $11.26&nbsp;at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44375647/canadian-cannabis-sndl-achieves-break-even-free-cash-flow-for-2024" target="_blank" rel="noreferrer noopener">Canadian Cannabis SNDL Achieves Break-Even Free Cash Flow For 2024</a></li>
</ul>
Photo: Shutterstock

Large Cap

Health Care

General

Walgreens' Executive Chair Stefano Pessina Seeks To Strengthen Control With Nearly Double Stake

Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) has been on a wild ride &#8211; up 215.99% over the past year, but down 33.51% in just the last month. The stock is now stuck below its key moving averages, flashing strong bearish signals. 
Can the upcoming AIPCon and a wave of high-profile deals set PLTR up for a turnaround?
<h2 class="wp-block-heading">Is PLTR Stock Facing A Technical Knockout?</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="618" height="487" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12070947/Screenshot-2025-03-12-at-4.37.59-PM.png" alt="" class="wp-image-820535" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12070947/Screenshot-2025-03-12-at-4.37.59-PM.png 618w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12070947/Screenshot-2025-03-12-at-4.37.59-PM-300x236.png 300w" sizes="(max-width: 618px) 100vw, 618px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
PLTR stock, at $78.05, is trading below its five, 20 and 50-day exponential moving averages, signaling continued selling pressure. The eight-day simple moving average (SMA) at $81.98, 20-day SMA at $94.60 and 50-day SMA at $86.96 all suggest the stock is still in bearish territory.
However, the 200-day SMA at $51.95 paints a different picture, hinting at longer-term strength.
Momentum indicators aren't helping the bulls either. The MACD at a negative 3.95 is firmly bearish, while the RSI at 39.82 signals PLTR stock isn't quite oversold yet.
Read Also: <a href="https://www.benzinga.com/markets/equities/25/03/44267822/palantir-executive-pushes-pentagon-to-adopt-software-first-approach-noting-us-allocates-less-than-1-of-defense-budget-to-modern-battlefield">Palantir Calls For &#8216;Software-First Approach&#8217; As Pentagon Spends Under 1% On Modern Warfare</a>
<h2 class="wp-block-heading">AIPCon &amp; New Deals: Can They Break The Trend?</h2>
Palantir is gearing up for its sixth AIPCon on March 13, where it will <a href="https://investors.palantir.com/news-details/2025/Palantirs-Latest-Wave-of-Customers-Take-Center-Stage-at-AIPCon/">showcase </a>new AI-driven partnerships. 
Big-name customers like Heineken NV (OTCPK:HEINY), Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) and AT&amp;T Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) are on board, while fresh government contracts, including a $178 million defense <a href="https://in.investing.com/news/company-news/palantir-to-host-aipcon-with-new-customer-reveals-93CH-4716118">deal</a> for mobile battle stations, keep rolling in.
On the tech front, Palantir is strengthening its grip in autonomous drones (<a href="https://in.benzinga.com/news/contracts/25/03/44248119/ondas-taps-palantirs-ai-to-scale-autonomous-systems-stock-jumps">Ondas Holdings partnership</a>) and space security (<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43170228/palantir-takes-aim-at-microsofts-22-billion-army-contract-as-ai-push-expands">Voyager Technologies collaboration</a>). 
But will these be enough to shift sentiment?
<h2 class="wp-block-heading">Long-Term Bulls Vs. Short-Term Bears</h2>
Despite its expanding influence, Palantir's stock is stuck in a bearish trend. AIPCon could provide the narrative boost bulls need, but the technicals suggest caution. 
For now, the stock remains a battleground between long-term believers and short-term skeptics.
Will Palantir stock break free from this slump or is the AI hype cooling off?
Investors will be watching closely.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44227856/nasdaq-sp-500-hit-6-month-lows-as-recession-fears-grow-whats-driving-markets-monday">Nasdaq, S&amp;P 500 Hit 6-Month Lows As Recession Fears Grow: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Technicals

Tech

HEINY

PLTR

Palantir's Stock Takes A Hit: Will AIPCon And Defense Deals Be The Comeback Catalyst?

<h2 class="wp-block-heading">New On The Block</h2>
Raizen, a Brazilian joint venture between Shell plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) and Cosan SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSAN#NYSE">CSAN</a>), tapped JPMorgan to shop around its Argentinian oil refinery and gas stations network. Bloomberg recently <a href="https://www.bloomberg.com/news/articles/2025-03-06/raizen-is-said-to-hire-jpmorgan-for-argentina-energy-assets-sale?srnd=phx-deals">reported</a> that the company is undergoing a "profound" portfolio revision, citing CEO Nelson Gomes&#8216;s comments to analysts during an earnings call.
<h2 class="wp-block-heading">Updates From The Block</h2>
Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) may be heading to the private sector, thanks to a $10 billion deal with Sycamore Partners. The transaction, approved by Walgreens&#8217; board, offers shareholders $11.45 per share in cash. Gary Black of The Future Fund LLC shared the news on social media, quipping, "I've talked before about how this company shouldn't be public." And who's pulling the strings? Executive chairman Stefano Pessina, who owns a 16.9% stake and clearly decided it was time to take his pharmacy empire <a href="https://www.benzinga.com/markets/equities/25/03/44185847/gary-black-says-walgreens-is-a-company-that-shouldnt-be-public-cites-largest-shareholders-role-in-10-billion-sycamore-deal">out of the public eye</a>.
President Donald Trump wants a U.S. sovereign wealth fund to buy TikTok&#8216;s U.S. business. That&#8217;s a bit like suggesting that a college student who is knee-deep in loans save up for a private jet. U.S. debt is exorbitant and the Trump administration is (they say) <a href="https://www.benzinga.com/news/25/03/44143475/trumps-u-s-doge-service-claims-65b-in-savings-experts-call-it-smoke-and-mirrors-amid-resignations">focused on reducing it</a>. However, <a href="https://www.reuters.com/markets/wealth/dealmaker-michael-grimes-expected-lead-new-us-sovereign-wealth-fund-sources-say-2025-03-05/?utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=newsletter_axiosprorata&amp;stream=top">Reuters</a> is reporting that Morgan Stanley&#8216;s Michael Grimes, who helped steer the Uber IPO and the Twitter takeover, is overseeing the formation of a sovereign wealth fund for Uncle Sam. But with TikTok&#8217;s April 5 deadline looming, time is of the essence. Tick tock. Pun intended.
Sure, a deal could get signed by then, but each passing day makes it feel more like a Hail Mary pass—except this time, instead of catching a football, the U.S. is hoping to catch a lip-syncing, trendsetting social media giant.
Meanwhile, Onsemi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) upped its bid for Allegro MicroSystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) to acquire the company for $35.10 per share, valuing the deal at $6.9 billion. This represents an increase over an initial $34.50 per share proposal submitted on Sept. 2.
<h2 class="wp-block-heading">Off The Block</h2>
American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) agreed to acquire Bellevue, Wash.-based Center, according to <a href="https://www.bloomberg.com/news/articles/2025-03-06/american-express-to-acquire-expense-management-company-center?srnd=phx-deals">Bloomberg</a>. Center is a software provider backed by Durable Capital Partners, Top Tier Capital Partners and Mango Capital.
<h2 class="wp-block-heading">Bankruptcy Block</h2>
Canoo, the electric vehicle startup that never quite got rolling, is getting a reboot—from its own CEO, no less. Anthony Aquila is buying nearly all of Canoo's assets out of bankruptcy for $4 million in cash, per <a href="https://techcrunch.com/2025/03/05/canoos-ceo-is-buying-the-bankrupt-ev-startups-assets/">TechCrunch</a>. The sale is expected to erase the $11 million debt Canoo owes to a financial firm&#8230; conveniently run by Aquila himself. Canoo filed for Chapter 7 liquidation just six weeks ago. Government contracts with NASA and the Department of Defense bore little fruit. The startup has roughly $145 million in assets but $175 million in liabilities. Now, other buyers can still throw their hats in the ring before March 28.
<h2 class="wp-block-heading">Notes From The Block</h2>
So much for the wave of M&amp;A dealmakers expected with Trump&#8217;s <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41979935/golden-years-for-ma-deals-ahead-under-trump-analysts-highlight-top-10-large-cap-candidates">return to the White House</a>. 
They banked on <a href="https://in.benzinga.com/news/25/02/44045159/trumps-plan-to-rein-in-regulators-could-erode-market-trust-says-2-3-trillion-asset-manager">looser regulations</a> and a more <a href="https://www.benzinga.com/25/03/44197558/whats-moving-markets-friday">vibrant stock market</a>. So far, neither scenario has come to fruition. According to Dealogic, U.S.-based M&amp;A volume is down about 29% compared to this timeframe in 2024. 
Consider the Federal Trade Commission&#8217;s (FTC) latest move. The agency, with a Trump appointee at the helm, is throwing a wrench into a private equity firm's plan to acquire Surmodics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRDX#NASDAQ">SRDX</a>), a company that specializes in drug delivery and in vitro diagnostic technologies.
The buyer, GTCR, already owns Biocoat, a Surmodics rival. Owning both would give them over 50% market control and the ability to squash competition. And the cost of the tech would indeed hurt the consumer. Since it's unlikely a new competitor would rise to challenge the dynamic duo of Biocoat and Surmodics, the FTC has taken the matter to court in the Northern District of Illinois.
For those surprised that the Trump administration isn&#8217;t letting this merger slide, recall his first term when the Department of Justice blocked deals between AT&amp;T and Time Warner; Sinclair and Tribune Media; Broadcom and Qualcomm as well as DraftKings and FanDuel.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/real-estate/25/03/44110974/halle-berry-launches-a-new-business-venture-succeeds-with-netflix-and-doubles-down-on-her-luxury-malibu-home">Halle Berry Launches A New Business Venture, Succeeds With Netflix, And Doubles Down On Her Luxury Malibu Home</a></li>
</ul>
For last week&#8217;s edition of <a href="https://www.benzinga.com/news/asset-sales/25/02/43897289/deal-dispatch-hooters-plans-restructuring-prada-in-talks-to-acquire-versace">Deal Dispatch, click here</a>.

Asset Sales

ALGM

CSAN

SHEL

SRDX

Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private

Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are moving higher on Friday after the company entered an agreement <a href="https://www.benzinga.com//node/44114248">to be acquired</a> by private equity firm Sycamore Partners.
The Details: Sycamore Partners will pay approximately $10 billion to acquire the chain drug store. This equates to $11.45 per share, which represents an 8% premium over the stock&#8217;s closing price of $10.60 on Thursday.
Shareholders might receive an extra $3 in cash from the future monetization of the company's debt and equity holdings in VillageMD, a primary-care provider.
This deal comes after Walgreens has spent years struggling to compete with retail giants like Amazon and Walmart. The chain&#8217;s market capitalization has declined by 90% over the last decade.
Under CEO Tim Wentworth, the company began closing stores and cutting costs through a $1 billion program. Wentworth emphasized that while progress has been made in the company&#8217;s turnaround efforts, creating significant value will require time, focus and changes that are more effectively managed as a private company.
Sycamore Partners has experience acquiring major retail chains, having previously purchased Staples in a $6.9 billion deal before breaking the office supply company into separate parts.
&#8220;You have a business that is shrinking, and then you layer on losses and cash burn, all of that was the perfect recipe for what we are seeing today,&#8221; Brian Tanquilut, a healthcare services research analyst at Jefferies, told Reuters.
Related Link: <a href="https://www.benzinga.com/insights/news/25/03/44190588/heres-how-much-1000-invested-in-ferrari-5-years-ago-would-be-worth-today">Here&#8217;s How Much $1000 Invested In Ferrari 5 Years Ago Would Be Worth Today</a>
WBA Price Action: At the time of publication, Walgreens stock is trading 7.12% higher at $11.36, according to data form <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Walgreens Boots Alliance, Inc.

Movers

What's Going On With Walgreens Stock Friday?

Investors holding ETFs with exposure to Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) are closely watching how the company's buyout by Sycamore Partners will impact their portfolios. As Walgreens <a href="https://www.benzinga.com/general/market-summary/25/03/44102644/walgreens-could-go-private-this-week-after-a-10-billion-deal-with-sycamore-partners-report">prepares to go private</a>, ETFs that currently hold its stock will need to readjust their allocations. Let's dive into how this transition could play out for <a href="https://www.benzinga.com/etfs">some key ETFs</a>.
Also Read: <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44182479/walgreens-stock-rises-as-company-inks-10b-deal-to-go-private">Walgreens Stock Rises As Company Inks $10B Deal To Go Private</a>
ETFs With Walgreens Exposure: What's At Stake?
SPDR S&amp;P Retail ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XRT#NYSE">XRT</a>): This ETF provides broad exposure to the retail sector, including Walgreens (almost 2% allocation). Since Walgreens is being delisted from the Nasdaq upon the deal's completion, XRT will need to rebalance its holdings, shifting funds to other retail stocks. This reallocation could create short-term volatility but will ultimately diversify its exposure further. The ETF was up 0.04% on Thursday.
Invesco S&amp;P 500 Pure Value ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPV#NYSE">RPV</a>): As a fund focused on undervalued stocks, RPV has included Walgreens due to its relatively low valuation. With WBA exiting the public market, RPV will likely redistribute its assets toward other value stocks in the consumer sector. This fund also saw a marginal gain of 0.12% on Thursday.
Invesco S&amp;P 500 Equal Weight Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSPS#NYSE">RSPS</a>): RSPS applies an equal-weight strategy within the consumer staples sector, where Walgreens has been a key player. The buyout will remove WBA from its holdings, allowing other consumer staples stocks to gain weight in the index. The ETF gained 0.62% at market close on Thursday.
The Deal: Walgreens Goes Private
Walgreens has agreed to be taken private by Sycamore Partners in a $10 billion deal, offering shareholders $11.45 per share in cash, with additional potential payouts linked to the monetization of VillageMD. While this provides an immediate cash payout for Walgreens shareholders, it also means that ETFs holding WBA shares must adjust.
For now, Walgreens remains a publicly traded company, but as the deal progresses, ETFs will prepare to rebalance. Since none of these ETFs rely heavily on a single stock, the broader impact should be manageable. Retail-focused ETFs like XRT may see some short-term fluctuations, while value-oriented funds like RPV will likely scout for alternative investments. However, the Walgreens buyout will not upend their strategies. 
The Walgreens buyout comes at a time when the retail sector is navigating mixed earnings reports. Several major retailers have reported varied results, reflecting shifting consumer spending habits amid inflationary pressures and economic uncertainty. While some companies have exceeded expectations, others have issued cautious guidance, impacting sector-wide sentiment.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/03/44176027/geopolitics-tariffs-supply-glut-whats-next-for-oil-etfs">Geopolitics, Tariffs, Supply Glut: What&#8217;s Next For Oil ETFs?</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

ETFs

RSPS

Retail ETFs Anticipate Adjustments As Walgreens Prepares To Go Private

U.S. stocks were higher, with the Dow Jones gaining around 100 points on Friday.
Shares of American Public Education, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/APEI/earnings">quarterly financial results</a>.
American Public Education reported quarterly earnings of 63 cents per share which beat the analyst consensus estimate of 54 cents per share. The company reported quarterly sales of $164.11 million which beat the analyst consensus estimate of $161.70 million.
American Public Education shares surged 33% to $25.60 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Willdan Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLDN#NASDAQ">WLDN</a>) gained 19.6% to $38.53 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) shares jumped 16.5% to $6.16.</li>
<li>Hawaiian Electric Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HE#NYSE">HE</a>) rose 13.2% to $11.77.</li>
<li>LZ Technology Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) shares jumped 12.7% to $11.07.</li>
<li>Ameresco, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRC#NYSE">AMRC</a>) gained 12.6% to $10.46.</li>
<li>MeridianLink, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) rose 11.5% to $20.55 following strong quarterly sales.</li>
<li>Tuya Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TUYA#NYSE">TUYA</a>) gained 9.7% to $3.7750.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) gained 8.2% to $11.74.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) rose 7.6% to $11.40 after the company entered an agreement to be acquired by Sycamore Partners.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) rose 7.2% to $21.20.</li>
<li>Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) gained 7% to $35.42. The company announced a major reduction in its workforce, impacting around 340 employees within its Technology division.</li>
<li>Sandisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) shares rose 6.6% to $49.56.</li>
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) gained 5.4% to $189.11 following better-than-expected first-quarter financial results and strong second-quarter guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44189316/this-bank-of-america-analyst-turns-bullish-here-are-top-5-upgrades-for-friday-3">This Bank of America Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday</a></li>
</ul>

Intraday Update

AMRC

APEI

ARRY

LZMH

MLNK

SNDK

TUYA

WLDN

American Public Education Posts Better-Than-Expected Earnings, Joins Willdan Group, Broadcom, Walgreens Boots Alliance And Other Big Stocks Moving Higher On Friday

WIIM

Walgreens Boots Alliance shares are trading higher after the company entered an agreement to be acquired by Sycamore Partners.

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) has entered into a definitive agreement to be taken private by Sycamore Partners in a deal valued at $10 billion, the company announced Thursday. The transaction, unanimously approved by Walgreens&#8217; board, offers shareholders $11.45 per share in <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44182479/walgreens-stock-rises-as-company-inks-10b-deal-to-go-private">cash at closing</a>.
What Happened: Gary Black, Managing Partner at The Future Fund LLC, highlighted the deal on X, saying WBA will be taken private by Sycamore Partners at $11.45 per share. He noted, &#8220;I&#8217;ve talked before about how this company shouldn&#8217;t be public,&#8221; adding that the move is driven by its largest shareholder, Executive chairman Stefano Pessina, who holds a 16.9% stake.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24WBA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$WBA</a> has agreed to be taken private by Sycamore Partners at $11.45/share. I've talked before about how this company shouldn't be public; it will now go private in a deal driven by its largest shareholder (Stefano Pessina 16.9% ownership) and reinforces that stocks that trade at…
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1897784976592249113?ref_src=twsrc%5Etfw">March 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The agreement includes an additional potential payout of up to $3 per share from the future monetization of Walgreens&#8217; interests in VillageMD, which encompasses Village Medical, Summit Health, and CityMD businesses.
&#8220;While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company,&#8221; said Tim Wentworth, CEO of Walgreens. &#8220;Sycamore will provide us with the expertise and experience of a partner with a strong track record of successful retail turnarounds.&#8221;
Why It Matters: The transaction is expected to close in the fourth quarter of 2025, after which Walgreens will be delisted from the Nasdaq. WBA shares rose 5.85% in after-hours trading to $11.22 following the announcement.
The deal comes as Walgreens faces valuation challenges, with Black noting the company trades at &#8220;5x EV/EBITDA backed by strong secular megatrends (e.g., people living longer).&#8221; Recent analyst coverage shows a <a href="https://www.benzinga.com/quote/WBA/analyst-ratings">consensus price target</a> of $20.82, suggesting the private equity deal may undervalue the company&#8217;s long-term potential.
<figure class="wp-block-image aligncenter size-full is-resized"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/07010251/Screenshot-2025-03-07-at-11.31.55%E2%80%AFAM.png" alt="" class="wp-image-813462" style="width:604px;height:auto" /></figure>
Walgreens is scheduled to release its second-quarter financial results on Apr. 8, with analysts expecting earnings of 52 cents per share and revenue of $38.04 billion, <a href="https://www.benzinga.com/pro/">according to Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44065932/mark-cuban-was-asked-how-hed-invest-100k-his-answer-buy-bulk-toothpaste-and-soup-for-the-best-guaranteed-return-on-investment" target="_blank" rel="noreferrer noopener">Mark Cuban Was Asked How He'd Invest $100K — His Answer? Buy Bulk Toothpaste And Soup For The ‘Best Guaranteed Return On Investment'</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Gary Black Says Walgreens Is A Company That 'Shouldn't Be Public,' Cites Largest Shareholder's Role In $10 Billion Sycamore Deal

The U.S. stock market slid today, with the Nasdaq Composite tumbling over 489 points to 18,069.25, a drop of 2.6%. The Dow dipped nearly 1% to 42,579.08, while the S&amp;P 500 declined about 1.8% to 5,738.52.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)
The stock closed down 6.33% at $179.45, with an intraday high and low of $186.83 and $177.61, respectively. Its 52-week high and low stand at $251.88 and $119.76. Broadcom reported a <a href="https://www.benzinga.com/news/earnings/25/03/44181200/broadcom-stock-surges-on-q1-earnings-beat-revenue-beat-strong-guidance-we-expect-continued-strength-in-ai-semiconductor-revenue">first-quarter revenue</a> of $14.92 billion, surpassing analyst estimates of $14.61 billion.
Costco Wholesale Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>)
Costco&#8217;s stock fell by 2.02% to close at $1,026.62. The stock&#8217;s intraday high and low were $1,045.89 and $1,019.05, with a 52-week range of $1,078.24 to $697.27. <a href="https://in.benzinga.com/news/earnings/25/03/44180426/costco-q2-earnings-revenue-beat-eps-miss-comps-up-68-driven-by-strength-in-the-us">The company reported</a> second-quarter revenue of $62.72 billion, beating the consensus estimate of $63.13 billion.
Intuitive Machines Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>)
Intuitive Machines saw a drastic drop of 20.20% to close at $11.26. The stock hit an intraday high and low of $14.08 and $10.25, with a 52-week high and low of $24.95 and $3.15.&nbsp;<a href="https://www.benzinga.com/general/space/25/03/44181829/intuitive-machines-stock-is-in-free-fall-thursday-whats-going-on">The company&#8217;s shares fell</a>&nbsp;after its moon lander experienced technical issues during an attempted moon landing.
Walgreens Boots Alliance Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)
Walgreens&#8217; stock dipped 1.40% to close at $10.60. The intraday high and low were $10.78 and $10.56, with a 52-week range of $22.05 to $8.08. <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44182479/walgreens-stock-rises-as-company-inks-10b-deal-to-go-private">Walgreens announced</a> a deal to be acquired by Sycamore Partners for $10 billion, which is expected to close in the fourth-quarter of 2025.
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla&#8217;s stock closed down 5.61% at $263.45, with an intraday high and low of $272.65 and $260.02. Its 52-week high and low are $488.54 and $138.80, respectively. <a href="https://www.benzinga.com/25/03/44160707/tesla-to-put-up-third-megafactory-near-houston-texas-report">Tesla is reportedly planning</a> to establish a third megafactory in Texas after commencing production at its Shanghai facility.
Prepare for the day&#8217;s trading <a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a> by Benzinga.
Photo Courtesy: Shutterstock.com
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44183861/cathie-wood-smelling-ai-opportunity-ark-invest-buys-tempus-ai-dip-scoops-up-over-13-m-worth-of-stock">Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Broadcom, Costco, Intuitive Machines, Walgreens, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are trading higher in Thursday&#8217;s after-hours session after the company announced a deal to be <a href="https://in.benzinga.com/general/market-summary/25/03/44102644/walgreens-could-go-private-this-week-after-a-10-billion-deal-with-sycamore-partners-report">acquired by Sycamore Partners</a>.
What Happened: After the market close on Thursday, Walgreens announced it entered into a definitive agreement to be taken private by an entity affiliated with Sycamore Partners for $10 billion.
Walgreens shareholders will receive $11.45 per share in cash at closing. Shareholders are also eligible to receive up to $3 in cash per share from the future monetization of Walgreens&#8217; debt and equity interests in VillageMD, which includes the Village Medical, Summit Health and CityMD businesses.
&#8220;While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company. Sycamore will provide us with the expertise and experience of a partner with a strong track record of successful retail turnarounds,&#8221; said Tim Wentworth, CEO of Walgreens.
&#8220;The WBA Board considered all these factors in evaluating this transaction, and we believe this agreement provides shareholders premium cash value, with the ability to benefit from additional value creation going forward from monetization of the VillageMD businesses.&#8221;
See Also: <a href="https://www.benzinga.com/news/earnings/25/03/44181200/broadcom-stock-surges-on-q1-earnings-beat-revenue-beat-strong-guidance-we-expect-continued-strength-in-ai-semiconductor-revenue">Broadcom Stock Surges On Q1 Earnings Beat, Revenue Beat, Strong Guidance: &#8216;We Expect Continued Strength In AI Semiconductor Revenue&#8217;</a>
Walgreens&#8217; board unanimously approved the proposed transaction, which is expected to close in the fourth quarter of 2025. Upon completion of the transaction, Walgreens will become a private company and the company&#8217;s common stock will be delisted from the Nasdaq.
Walgreens noted it will release its <a href="https://www.benzinga.com/calendars/earnings">second-quarter financial results</a> on April 8. Analysts currently expect the company to report earnings of 52 cents per share and revenue of $38.04 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
WBA Price Action: <a href="http://benzinga.com/quote/wba">Walgreens shares</a> were up 5.85% after hours, trading at $11.22 at the time of publication Thursday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Courtesy of Walgreens Boots Alliance.

After-Hours Center

Walgreens Stock Rises As Company Inks $10B Deal To Go Private

Trading Halt: Halt status updated at 5:40:00 PM ET: Quotation Resumption: News and Resumption Times

The Cash Consideration represents a premium of 29%, and the Total Consideration represents a premium of up to 63%, to the WBA closing share price of $8.85 on December 9, 2024, the day prior to the first media reports regarding a potential transaction.
The transaction is expected to close in the fourth quarter calendar year 2025.
Upon completion of the transaction, WBA's common stock will no longer be listed on the Nasdaq Stock Market, and WBA will become a private company. &nbsp;
&nbsp;

Walgreens Boots Alliance Says Total Deal Consideration Consists of $11.45 Per Share in Cash And Additional Potential Value Of Up To $3.00 in Cash Per WBA Share From Future Monetization Of VillageMD Businesses

Walgreens Boots Alliance Agrees To Be Acquired By Sycamore Partners; Total Value Of Transaction Represents Up To $23.7B

Trading Halt: Halted at 5:14:09 p.m. ET - Trading Halt: Halt News Pending

Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are trading higher on Tuesday following a report suggesting that the company is <a href="https://www.benzinga.com//node/44102644">nearing a deal</a> with private-equity firm Sycamore Partners.
What To Know: According to <a href="https://www.wsj.com/business/deals/walgreens-nears-roughly-10-billion-deal-to-be-go-private-ee07f2fa">The Wall Street Journal</a>, the companies are aiming to finalize the approximately $10 billion deal that would take Walgreens private by Thursday, assuming no unexpected obstacles.
Currently, discussions suggest that Sycamore may pay between $11.30 and $11.40 per share in cash. Additionally, the deal might include contingent value rights, which could enhance the overall value if specific milestones are met.
Sycamore is anticipated to hold on to the main U.S. business, whiling selling off or taking public other parts of the company.
Walgreens would not be Sycamore&#8217;s first time taking a large retail chain off the market. Previously, the private-equity firm purchased Staples in a $6.9 billion deal before splitting the office supply company into separate parts.
See Also: <a href="https://www.benzinga.com/news/contracts/25/03/44109280/whats-going-on-with-ionq-stock-today-6">What&#8217;s Going On With IonQ Stock Today?</a>
WBA Price Action: At the time of publication, Walgreens stock is trading 6.9% higher at $10.97, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

What's Going On With Walgreens Stock Tuesday?

CAPR: 20% &#x7C; <a href="https://www.benzinga.com//node/44104968">Capricor Therapeutics shares are trading higher after the FDA accepted and granted priority review for the company's Biologics License Application for Deramiocel to treat Duchenne Muscular Dystrophy.</a>
&nbsp;
WBA: 7% &#x7C; <a href="https://www.benzinga.com//node/44104926">Walgreens Boots Alliance shares are trading higher following a WSJ report suggesting the company is nearing a go-private deal with Sycamore Partners.</a>
&nbsp;
GCT: -20% &#x7C; <a href="https://www.benzinga.com//node/44104955">GigaCloud Tech shares are trading lower after the company issued Q1 sales guidance below estimates.</a>

CAPR

Market-Moving News for March 4th

Walgreens Boots Alliance shares are trading higher following a WSJ report suggesting the company is nearing a go-private deal with Sycamore Partners.

U.S. stock futures declined on Tuesday following the worst trading day of 2025 on Monday. Futures of all benchmark indices fell in premarket trading except Nasdaq 100.
Investor anxiety over tariffs loomed as the March 4 deadline for tariff imposition on Mexico and Canada neared. President Donald Trump indicated on Monday that there was &#8220;no room left&#8221; for tariff negotiations with Canada and Mexico. He will be addressing the Congress today, which is expected to give further clarity on tariffs and other policies.
Meanwhile, the Treasury yields slipped further on Tuesday. The 10-year Treasury yield stood at 4.16%, while the two-year yield was at 3.93%. According to the CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, there is a 91% chance that the Federal Reserve will keep interest rates unchanged for the March meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.03%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.06%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.07%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.33%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Tuesday. SPY was up 0.046% to $584.04, and QQQ advanced 0.23% to $498.20, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Real estate, consumer staples, health care and utilities were the only sectors that advanced on Monday. The market witnessed the second worst trading day of March ever as information technology, energy, consumer discretionary, and materials led the decline.
On the economic front, February&#8217;s S&amp;P final U.S. manufacturing PMI came in at 52.7 as compared to the preliminary reading of 51.6. This was at a 32-month high signaling an improvement in the health of the manufacturing sector.
The ISM Manufacturing PMI rose to 50.3 in February 2025, indicating a second consecutive month of slight expansion for U.S. manufacturing. In January, private residential construction spending decreased by 0.4%, with notable reductions in both multifamily construction and home improvement expenditures.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-2.64%</td>
<td>18,350.19</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-1.76%</td>
<td>5,849.72</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-1.48%</td>
<td>43,191.24 </td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-2.81%</td>
<td>2,102.24</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
Bearish investor sentiment surged to a near-historic 60.6% in late February, the highest in 30 months, signaling a potential contrarian buying opportunity.
Ryan Detrick of Carson Research noted that historically, stocks average a 28% gain a year after such high bearish readings, although exceptions like 2008 exist. He observed that even at a 55% bearish threshold, returns are generally strong.
Detrick suggests that barring a financial crisis, which he deems unlikely, "investors willing to stay strong and not panic sell" could see significant gains, with the S&amp;P 500 averaging nearly 13% higher in six months and 18% in a year following similar sentiment spikes.
Talking about the effects of Trump's policies on the market, the chairman and CIO of Navellier &amp; Associates, Louis Navellier said, "The volatility is certainly being fed by Trump 2.0 moves, with tariffs scheduled to be launched soon,"
Economist Jeremy Siegel, on the other hand, stated that investors are taking profits on high-flying tech and reconsidering value stocks. However, he added that slowing economic growth could hamper the value stocks as well. "In a weakening economy, all stocks face challenges, though dividend-paying and more defensive equities may benefit from lower interest rates," he added.
See Also:<a href="https://www.benzinga.com/money/how-to-trade-futures"> How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep on Tuesday:
<ul>
<li>New York Fed President John Williams will speak at 2:20 p.m. ET, whereas, Richmond Fed President Tom Barkin will speak at an undetermined time.</li>
</ul>
Stocks In Focus:
<ul>
<li>Crowdstrike Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) was up 0.34% in the premarket on Tuesday ahead of its earnings, which will be released after the opening bell. Analysts expect it to report earnings of 86 cents per share on revenue of $1,034.3 million.</li>
</ul>
<ul>
<li>Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) advanced 0.39% as Wall Street expects it to report quarterly earnings of $2.25 per share on revenue of $30.85 billion before the opening bell.</li>
</ul>
<ul>
<li>Green Dot Corporation. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDOT#NYSE">GDOT</a>) jumped 15.50% as it surpassed fourth-quarter earnings and revenue expectations and appointed Kim Olson as the new CFO.</li>
</ul>
<ul>
<li>Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) climbed 6.14% as private equity firm Sycamore Partners could take the company private by Thursday this week, reported WSJ.</li>
</ul>
<ul>
<li>Sacks Parente Golf Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) slumped 37.16% after it announced a 1-for-30 reverse stock split.</li>
</ul>
<ul>
<li>Tenaya Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNYA#NASDAQ">TNYA</a>) dropped 25.02% as the company announced plans for a public offering of units, including common stock and two warrant series, plus pre-funded units with immediately exercisable warrants.</li>
</ul>
<ul>
<li>Sphere Entertainment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) was 0.16% lower as it missed the earnings estimates.</li>
</ul>
<ul>
<li>Biodesix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) surged 18.65% after reporting a total revenue reaching $71.3 million, up 45% year-on-year.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 1.11% to hover around $67.61 per barrel.
The gold spot index was up by 0.90% to $2,919.13 per ounce. Its last record high was at $2,956.37 per ounce. The Dollar Index was down 0.46% at the 106.254 level.
Asian markets were lower on Tuesday as India's S&amp;P BSE Sensex, China's CSI 300, South Korea's Kospi, Japan's Nikkei 225, Australia's ASX 200, and Hong Kong's Hang Seng index declined. European markets were also lower in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44070799/mark-cuban-supports-trumps-new-gold-card-scheme-if-sold-to-corporations-for-employee-citizenship-have-a-look-at-the-listed-companies-with-most-number-of-immigrants">Mark Cuban Supports Trump&#8217;s New &#8216;Gold Card&#8217; Scheme If Sold To Corporations For Employee Citizenship: Here&#8217;re The Listed-Companies With Most Number Of Immigrants</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Government

Market Summary

Futures

Commodities

Economics

BDSX

CRWD

GDOT

SPGC

SPHR

TNYA

US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says Expert

Press Releases

Shareholders that lost money on Walgreens Boots Alliance, Inc.(WBA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Legal

Levi & Korsinsky Notifies Walgreens Boots Alliance, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – WBA

WBA Deadline: WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit

Walgreens Boots Alliance, Inc. Class Action: Levi & Korsinsky Reminds Walgreens Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - WBA

WBA DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action - WBA

Walgreens Boots Alliance, Inc. Class Action: The Gross Law Firm Reminds Walgreens Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - WBA

WBA DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action - WBA

Walgreens Boots Alliance, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before March 31, 2025 to Discuss Your Rights – WBA

WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit with the Schall Law Firm

U.S. Heating Pads Market Report 2023-2029: Bear Down Brands, LLC., Beurer and Conair LLC are the Major Stakeholders – Arizton

Guardian Pharmacy Services, Inc. Class A Common Stock

Guardian Pharmacy Service

Mangoceuticals

Ridgetech

Deutsche Bank

Truist Securities

RBC Capital

Evercore ISI Group

B of A Securities

Screenshot 2025-03-18 at 5.59.12 PM

Fintech news covering the emerging Financial Technology services sector

Fintech

AMOD

VSBGF

Alpha Modus: Helping Set IP Leadership Standards And Usher In A New Era Of Innovation In Retail AI

Screenshot 2025-02-21 at 6.41.09 PM

Emerging Markets

Movers & Shakers

From Innovating To Protecting Its Shareholders: Alpha Modus&#39;s Strategy To Transform The Retail Market

Comments

Walgreens Boots Alliance

Noticias

Últimas noticias sobre Walgreens Boots Alliance (NASDAQ:WBA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL